zinc finger protein 807, pseudogeneGenealiases: ZNF181P1 · ZNF807
Q-omics provides the consensus-scored ZNF807P profile across patient tissues and cancer cell-line models. ZNF807P expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, ZNF807P is differentially expressed in 5, with the highest sampling consensus in UCEC. Additionally, ZNF807P RNA expression shows 16,538 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCEC, and THYM as cancer lineages where ZNF807P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF807P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ZNF807P survival associations across molecular data types. ZNF807P RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF807P RNA expression–survival associations across cancer types. High ZNF807P expression shows unfavorable associations in UCEC, LUSC and KICH, but favorable associations in CHOL, ACC and KIRP. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UCEC as the clearest survival context for ZNF807P RNA expression.
This table summarizes ZNF807P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in UCEC for RNA.
This table ranks reproducible tumor–normal expression differences for ZNF807P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ZNF807P shows lower tumor expression in UCEC, BRCA, LUSC and THCA and higher tumor expression in PRAD. The UCEC box plot shows higher ZNF807P RNA expression in normal versus tumor tissue (log2 FC = −0.128, t-test p < 0.001).
This table shows molecular features associated with ZNF807P in patient tissues and cancer cell lines. In patient samples, ZNF807P shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
